Consequently, the ratios of both total and activated CD8+ and CD4+ T cells relative to Treg cells in the tumor more strongly favored the effector cells following Y33 IC alone or ICIs plus Y33 IC treatment compared with untreated mice and mice treated with ICIs alone or ICIs plus Control IC (figure 6J–M). This evidence concerns the gene CD8A and neoplasm.